K.J. Harrison & Partners’s BioNTech BNTX Stock Holding History

K.J. Harrison & Partners’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,300	Closed	-$222K	–	256
2022 Q1	$222K	Hold	1,300	–	–	0.04%	220
2021 Q4	$336K	Hold	1,300	–	–	0.05%	226
2021 Q3	$357K	Hold	1,300	–	–	0.05%	223
2021 Q2	$291	Buy	+1,300	New	+$245K	0.03%	240

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

K.J. Harrison & Partners's BNTX Position: Q2 2022 in Review

K.J. Harrison & Partners sold out of BioNTech (BNTX) in Q2 2022, closing a stake of 1,300 shares — an estimated $222K sold.

K.J. Harrison & Partners first reported a position in BNTX in Q2 2021 and held it in 4 quarters. The position peaked at $357K in Q3 2021. 293 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

K.J. Harrison & Partners reported no remaining BioNTech position as of Q2 2022 after selling out during the quarter.
K.J. Harrison & Partners sold 1,300 BioNTech shares in Q2 2022, an estimated $222K.
K.J. Harrison & Partners first reported a position in BioNTech in Q2 2021 and held it in 4 quarters.
K.J. Harrison & Partners's BioNTech position peaked at $357K in Q3 2021.
293 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on K.J. Harrison & Partners's 13F filing for Q2 2022, filed 27 Jul 2022.